Mira Pharmaceuticals (MIRA) Operating Expenses (2022 - 2025)

Mira Pharmaceuticals (MIRA) has 4 years of Operating Expenses data on file, last reported at $5.8 million in Q4 2025.

• Quarterly Operating Expenses rose 138.94% year-over-year to $5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (up 30.86% YoY) and the FY2025 annual result came in at $10.5 million, up 30.86% from the prior year.
• Operating Expenses climbed to $5.8 million in Q4 2025 per MIRA's latest filing, from $1.3 million in the prior quarter.
• The five-year high for Operating Expenses was $5.8 million in Q4 2025, with the low at $970220.0 in Q2 2023.
• Average Operating Expenses over 4 years is $2.2 million, with a median of $1.8 million recorded in 2024.
• The widest YoY moves for Operating Expenses: up 138.94% in 2025, down 36.73% in 2025.
• Mira Pharmaceuticals' Operating Expenses stood at $1.3 million in 2022, then surged by 126.78% to $3.1 million in 2023, then dropped by 20.24% to $2.4 million in 2024, then jumped by 138.94% to $5.8 million in 2025.
• Business Quant data shows MIRA's Operating Expenses at $5.8 million in Q4 2025, $1.3 million in Q3 2025, and $1.5 million in Q2 2025.